| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Alam | 2 | 0% |
| Examiner Boesen | 281 | 77% |
| Examiner Buckmaster | 23 | 0% |
| Examiner Chen | 366 | 72% |
| Examiner Chestnut | 573 | 89% |
| Examiner Cornelius | 1 | 0% |
| Examiner Grizer | 0 | 0% |
| Examiner Jadhao | 25 | 0% |
| Examiner Kinsey | 330 | 67% |
| Examiner Salvoza | 350 | 65% |
| Examiner Visone (SPE) | 182 | 55% |
| Examiner Wang | 47 | 47% |
| Art Unit 1672 | 2180 | 72% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 702 | Data processing: measuring, calibrating, or testing |
| 435 | Chemistry: molecular biology and microbiology |
| 514 | Drug, bio-affecting and body treating compositions |
| 703 | Data processing: structural design, modeling, simulation, and emulation |
| 560 | Organic compounds -- part of the class 532-570 series |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 706 | Data processing: artificial intelligence |
| 554 | Organic compounds -- part of the class 532-570 series |
| 562 | Organic compounds -- part of the class 532-570 series |
Art Unit 1672's grant rate is higher than that of Group 1670 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1672, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.